source
- FDA leadership overhaul follows firing of acting CDER director; 20 deaths linked to Amgen’s Tavneos in JapanThe FDA announced another leadership change, removing acting directors of its two main drug review centers. Tracy Beth Høeg, acting head of the Center for Drug Evaluation and Research (CDER), poste…
- Pharma firms turn to outsourcing to boost value of aging drug portfoliosFor many years pharma companies treated legacy brands as low-maintenance cash generators, focusing only on steady but declining revenue once patents expired. With the largest patent cliff in histo…